Clinical features of tic-related obsessive-compulsive disorder: results from a large multicenter study
Carregando...
Citações na Scopus
58
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
CAMBRIDGE UNIV PRESS
Autores
ROSARIO, Maria Conceicao do
FOSSALUZA, Victor
TORRES, Albina Rodrigues
Citação
CNS SPECTRUMS, v.17, n.2, p.87-93, 2012
Resumo
Objective. To evaluate the clinical features of obsessive-compulsive disorder (OCD) patients with comorbid tic disorders (TD) in a large, multicenter, clinical sample. Method. A cross-sectional study was conducted that included 813 consecutive OCD outpatients from the Brazilian OCD Research Consortium and used several instruments of assessment, including the Yale-Brown Obsessive-Compulsive Scale, the Dimensional Yale-Brown Obsessive-Compulsive Scale, the Yale Global Tic Severity Scale (YGTSS), the USP Sensory Phenomena Scale, and the Structured Clinical Interview for DSM-IV Axis I Disorders. Results. The sample mean current age was 34.9 years old (SE 0.54), and the mean age at obsessive-compulsive symptoms (OCS) onset was 12.8 years old (SE 0.27). Sensory phenomena were reported by 585 individuals (72% of the sample). The general lifetime prevalence of TD was 29.0% (n=236), with 8.9% (n=72) presenting Tourette syndrome, 17.3% (n=5141) chronic motor tic disorder, and 2.8% (n=523) chronic vocal tic disorder. The mean tic severity score, according to the YGTSS, was 27.2 (SE 1.4) in the OCD1TD group. Compared to OCD patients without comorbid TD, those with TD (OCD1TD group, n=236) were more likely to be males (49.2% vs. 38.5%, p<005) and to present sensory phenomena and comorbidity with anxiety disorders in general: separation anxiety disorder, social phobia, specific phobia, generalized anxiety disorder, post-traumatic stress disorder, attention-deficit hyperactivity disorder, impulse control disorders in general, and skin picking. Also, the ""aggressive,"" ""sexual/religious,"" and ""hoarding"" symptom dimensions were more severe in the OCD+TD group. Conclusion. Tic-related OCD may constitute a particular subgroup of the disorder with specific phenotypical characteristics, but its neurobiological underpinnings remain to be fully disentangled.
Palavras-chave
Comorbidity, obsessive-compulsive disorder, tic disorder, Tourette syndrome
Referências
- BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
- BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
- Bloch Michael H, 2008, Curr Psychiatry Rep, V10, P323, DOI 10.1007/s11920-008-0052-z
- Bloch MH, 2008, AM J PSYCHIAT, V165, P1532, DOI 10.1176/appi.ajp.2008.08020320
- Cath DC, 2001, J NERV MENT DIS, V189, P219, DOI 10.1097/00005053-200104000-00003
- Coffey BJ, 1998, J NERV MENT DIS, V186, P201, DOI 10.1097/00005053-199804000-00001
- de Mathis MA, 2008, EUR PSYCHIAT, V23, P187, DOI 10.1016/j.eurpsy.2008.01.002
- de Mathis MA, 2006, CNS SPECTRUMS, V11, P762
- de Mathis MA, 2009, CNS SPECTRUMS, V14, P362
- de Silva P, 1999, BEHAV RES THER, V37, P941, DOI 10.1016/S0005-7967(98)00185-5
- Diniz JB, 2004, J CLIN PSYCHIAT, V65, P22
- Diniz JB, 2006, J PSYCHIATR RES, V40, P487, DOI 10.1016/j.jpsychires.2006.09.002
- Ferrao YA, 2009, PSYCHIAT RES, V170, P32, DOI 10.1016/j.psychres.2008.06.008
- First M.B., 1995, STRUCTURED CLIN INTE
- Fontenelle LF, 2006, PROG NEURO-PSYCHOPH, V30, P327, DOI 10.1016/j.pnpbp.2005.11.001
- Fontenelle LF, 2012, J ANXIETY DISORD, V26, P377, DOI 10.1016/j.janxdis.2011.12.001
- Geller DA, 2006, PSYCHIAT CLIN N AM, V29, P353, DOI 10.1016/j.psc.2006.02.012
- GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
- Grabe HJ, 2008, PSYCHOPATHOLOGY, V41, P129, DOI 10.1159/000112029
- Hasler G, 2005, PSYCHIAT RES, V135, P121, DOI 10.1016/j.psychres.2005.03.003
- Hollander E, 2007, CNS SPECTRUMS, V12, P5
- Jaisoorya TS, 2008, CNS SPECTRUMS, V13, P705
- Leckman James F, 2009, Dialogues Clin Neurosci, V11, P21
- Koran LM, 1996, AM J PSYCHIAT, V153, P783
- LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015
- Leckman JF, 2008, AM J PSYCHIAT, V165, P1229, DOI 10.1176/appi.ajp.2008.08060891
- MCDOUGLE CJ, 1994, ARCH GEN PSYCHIAT, V51, P302
- MCDOUGLE CJ, 1993, J CLIN PSYCHOPHARM, V13, P354
- Miguel E C, 2001, Adv Neurol, V85, P43
- Miguel EC, 2008, REV BRAS PSIQUIATR, V30, P185
- Miguel EC, 2009, REV BRAS PSIQUIATR, V31, P85
- Miguel EC, 1997, BRIT J PSYCHIAT, V170, P140, DOI 10.1192/bjp.170.2.140
- Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617
- MIGUEL EC, 1995, J CLIN PSYCHIAT, V56, P246
- Niederauer KG, 2007, REV BRAS PSIQUIATR, V29, P271, DOI 10.1590/S1516-44462006005000050
- Petter T, 1998, J CLIN PSYCHIAT, V59, P456, DOI 10.4088/JCP.v59n0903
- Potenza MN, 2009, PSYCHIAT RES, V170, P21
- Rosario MC, 2009, CNS SPECTRUMS, V14, P315
- Rosario-Campos M C, 2001, Am J Psychiatry, V158, P1899
- Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798
- Rosario-Campos MC, 2005, AM J MED GENET B, V136B, P92
- Torres AR, 2005, REV BRAS PSIQUIATR, V27, P237
- Walitza S, 2008, J NEURAL TRANSM, V115, P187, DOI 10.1007/s00702-007-0841-2
- WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5